SG Americas Securities
PAVM icon

SG Americas Securities’s PAVmed PAVM Stock Holding History

SG Americas Securities’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-186
Closed -$111K – 3555
2022
Q1 		$111K Buy
186
+147
+377% +$109K ﹤0.01% 2728
2021
Q4 		$44K Sell
39
-36
-48% -$78.3K ﹤0.01% 3206
2021
Q3 		$289K Buy
+75
New +$236K ﹤0.01% 2975
2021
Q2 		– Sell
-24
Closed -$49K – 3140
2021
Q1 		$49K Buy
+24
New +$36.1K ﹤0.01% 3164
2020
Q3 		– Sell
-43
Closed -$41K – 3259
2020
Q2 		$41K Buy
+43
New +$43K ﹤0.01% 3563

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's PAVM Position: Q2 2022 in Review

SG Americas Securities sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 186 shares — an estimated $111K sold.

SG Americas Securities first reported a position in PAVM in Q2 2020 and held it in 5 quarters. The position peaked at $289K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • SG Americas Securities reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • SG Americas Securities sold 186 PAVmed shares in Q2 2022, an estimated $111K.
  • SG Americas Securities first reported a position in PAVmed in Q2 2020 and held it in 5 quarters.
  • SG Americas Securities's PAVmed position peaked at $289K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on SG Americas Securities's 13F filing for Q2 2022, filed 29 Jul 2022.